362649-75-0

Upstream product

• 362649-71-6 (1S,3aR,4S,7aS)-1-{(R)-1-[3-(1-Hydroxy-cyclohexyl)-prop-2-ynyloxy]-ethyl}-7a-methyl-octahydro-inden-4-ol 
• 108-94-1 cyclohexanone 
• 147725-63-1 (8β,20R)-8-[(tert-butyldimethylsilyl)oxy]des-A,B-pregnan-20-ol 
• 362649-70-5 (1S,3aR,4S,7aS)-7a-Methyl-1-((R)-1-prop-2-ynyloxy-ethyl)-octahydro-inden-4-ol 
• 362649-78-3 tert-Butyl-dimethyl-[(1S,3aR,4S,7aR)-7a-methyl-1-((R)-1-prop-2-ynyloxy-ethyl)-octahydro-inden-4-yloxy]-silane 

Downstream Products

• 362649-76-1 (1S,3aR,7aR)-7a-Methyl-1-{(R)-1-[3-(1-trimethylsilanyloxy-cyclohexyl)-prop-2-ynyloxy]-ethyl}-octahydro-inden-4-one 

Relevant academic research and scientific papers

Conformationally restricted hybrid analogues of the hormone 1α,25-dihydroxyvitamin D3: Design, synthesis, and biological evaluation

Four new conformationally restricted hybrid analogues of the hormone 1α-25-dihydroxyvitamin D3 (1,25D3) have been synthesized in a convergent manner by combining enantiomerically pure C,D-ring ketones ( - )-15 and ( - )-17 with racemic 1-hydrox